Latest Views & News

Instem – “as a result of strong institutional investor demand”, ‘long term shareholders’ including directors sell… at a good price then?

By Steve Moore | Thursday 11 April 2019


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Provider of IT services to the life sciences market, Instem (INS) has announced shareholders including the DG 2008 Discretionary Settlement (of which Chairman David Gare and his wife are trustees) and non-executive director David Sherwin have sold shares… “as a result of strong institutional investor demand following our recent results”. With such demand seemingly unable to be met by the market, a good price in relation to a last close 330p share price then?...

You must be a registered member to read this story
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

SAGA

The ongoing saga of woe at Saga

 

Quiz

The ShareProphets Sunday Pub Quiz #160

 

VCP

Gyrations at Victoria Carpets

 

MADE

GOTCHA: Made.com admits it is fucked

 

Bull

Stuff happens but we are not stuffed

 

Quiz

The ShareProphets Sunday Pub Quiz #159

 

OCDO

Challenges continue at Ocado

 

ICON

Iconic Labs – back from the dead?

 

PUR

Pure Gold – Pure Ramping!

Sunday »

Quiz

The ShareProphets Sunday Pub Quiz #158

 

ORCA

Buy Orcadian Energy